Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.29 CAD | -4.22% | -0.30% | -16.71% |
Jun. 07 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
May. 28 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.71% | 79.64M | |
+31.26% | 78.23B | |
+5.13% | 8.76B | |
+13.69% | 8.68B | |
-30.46% | 6.95B | |
+16.85% | 5.35B | |
+3.30% | 4.15B | |
-8.76% | 3.82B | |
-6.88% | 3.42B | |
+9.05% | 3.24B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Announces Retirement Of 2 Board Directors, Strikes Agreement with Polar Asset Management Partners